Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock

Publikation: Bidrag til tidsskriftReviewForskningpeer review


  1. Association between inflammatory markers and survival in comatose, resuscitated out-of-hospital cardiac arrest patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. A new method to quantify left ventricular mass by 2D echocardiography

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Association Between EEG Patterns and Serum Neurofilament Light After Cardiac Arrest: A Post Hoc Analysis of the TTM Trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Acute myocardial infarction complicated by cardiogenic shock (AMICS), is characterized by critically low cardiac output and decreased myocardial contractility. In this situation, a treatment that unloads the myocardium and restores CO without increasing the myocardial oxygen demand is theoretically appealing. Axial flow pumps offer hemodynamic support without increasing myocardial oxygen consumption. Consequently, the use of axial flow pumps, especially the Impella devices, is increasing. It is likely that the SCAI C patient with predominantly left ventricular failure and without prolonged cardiac arrest is the best candidate for these devices. Registry data suggest that pre-PCI Impella may be advantageous to post-PCI placement. However, several gaps in knowledge exist regarding optimal patient selection, futility criteria, timing, weaning and escalation strategy, and until data from adequately sized randomized trials are available, immediate individual evaluation for mechanical circulatory support by a shock team is warranted when a patient is diagnosed with AMICS.

TidsskriftJournal of Clinical Medicine
Udgave nummer9
StatusUdgivet - 26 apr. 2022

ID: 77990293